Precision for Medicine
Precision for Medicine, a Clinical Research Organization focused on precision medicine in areas like rare diseases and oncology, is seeking a Site Start Up Lead to manage and coordinate site start-up activities across various countries. The role involves strategy development, stakeholder collaboration, and ensuring timely activation of clinical sites.
Headquarters
Bethesda, Maryland, United States
Company Size
1001-5000 employees
Founded
2013
Precision for Medicine is a global clinical research organization (CRO) that uses advanced technologies and translational science to maximize insights into patient biology and inform drug development. They offer integrated services—including biomarker strategy, bioanalysis, multi‑omics and data analytics—alongside clinical trial design and execution to support precision medicine programs. Their platform-driven approach helps sponsors improve patient selection, de‑risk development, and accelerate timelines across therapeutic areas. Precision for Medicine partners with biotech and pharma to move candidates from early development toward approval.
Nicholas Richardson joins Precision for Medicine as vice president of clinical development
Sep 26, 2025
Precision Announces Promotion of Sofia Baig to President, Precision for Medicine and Appointment of Daisy DeWeese-Gatt, MPH, as President, Clinical Solutions, Precision for Medicine
May 20, 2025
Bringing attention to the ‘Big Five Fatigue’ of CROs
Jul 14, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Precision for Medicine.
Precision for Medicine didn’t post a salary, so this is our estimate from similar listings.
21% above the average for this role
Unpacking the Complexities of Companion Diagnostics for Cell and Gene Therapies
Jun 10, 2025